Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Boosted by Northeast Investment Management

Northeast Investment Management grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 92,474 shares of the medical equipment provider’s stock after purchasing an additional 3,304 shares during the period. Intuitive Surgical comprises 2.1% of Northeast Investment Management’s portfolio, making the stock its 13th largest holding. Northeast Investment Management’s holdings in Intuitive Surgical were worth $45,800,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in ISRG. USA Financial Formulas lifted its position in Intuitive Surgical by 90.6% in the 1st quarter. USA Financial Formulas now owns 4,476 shares of the medical equipment provider’s stock worth $2,217,000 after buying an additional 2,128 shares in the last quarter. Rowlandmiller & PARTNERS.ADV raised its holdings in shares of Intuitive Surgical by 7.9% during the first quarter. Rowlandmiller & PARTNERS.ADV now owns 2,572 shares of the medical equipment provider’s stock worth $1,274,000 after acquiring an additional 188 shares in the last quarter. CX Institutional boosted its position in Intuitive Surgical by 2.6% during the first quarter. CX Institutional now owns 1,873 shares of the medical equipment provider’s stock valued at $928,000 after purchasing an additional 48 shares during the last quarter. MV Capital Management Inc. grew its stake in Intuitive Surgical by 92.8% in the first quarter. MV Capital Management Inc. now owns 532 shares of the medical equipment provider’s stock valued at $263,000 after purchasing an additional 256 shares in the last quarter. Finally, Franklin Street Advisors Inc. NC increased its position in Intuitive Surgical by 62.0% in the 1st quarter. Franklin Street Advisors Inc. NC now owns 39,299 shares of the medical equipment provider’s stock worth $19,464,000 after purchasing an additional 15,044 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Up 0.7%

Shares of NASDAQ ISRG opened at $529.60 on Wednesday. Intuitive Surgical, Inc. has a 12 month low of $413.82 and a 12 month high of $616.00. The company has a market cap of $189.82 billion, a P/E ratio of 82.62, a P/E/G ratio of 5.85 and a beta of 1.67. The business’s 50 day moving average is $523.08 and its two-hundred day moving average is $538.95.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the previous year, the firm posted $1.50 earnings per share. Sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages recently commented on ISRG. Evercore ISI lowered their price target on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating for the company in a research note on Wednesday, April 23rd. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Thursday, June 5th. BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the stock a “buy” rating in a research note on Monday, April 14th. Royal Bank of Canada reduced their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a research note on Wednesday, April 23rd. Finally, Robert W. Baird decreased their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $588.95.

Insider Activity

In related news, SVP Mark Brosius sold 216 shares of the company’s stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the transaction, the senior vice president now directly owns 907 shares in the company, valued at approximately $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of the firm’s stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the transaction, the director now owns 6,371 shares of the company’s stock, valued at approximately $3,312,920. This represents a 27.36% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 16,543 shares of company stock valued at $8,375,072. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.